Home
Magna Scientia Advanced Biology and Pharmacy
Peer-Reviewed • ISSN: 2582-8363 • Fast-Track Publishing • Impact Factor 8.6 • Low Publication Charges • Crossref DOI Linking

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September - October 2026 (Volume 19, Issue 1) Submit manuscript

The use of Dermacell® Allograft in a diabetic patient with critical limb ischemia

Breadcrumb

  • Home
  • The use of Dermacell® Allograft in a diabetic patient with critical limb ischemia

Vangelis G Alexiou 1, Stylianos G. Koutsias 1 and Bertasi Giampietro 2, *

1 Vascular Surgery Unit, Department of Surgery, Ioannina University Hospital, Ioannina, Greece.
2 Biotechnology Dept., University of Padua, Italy.
 
Case Study
Magna Scientia Advanced Biology and Pharmacy, 2022, 06(01), 033–035
Article DOI: 10.30574/msabp.2022.6.1.0068
DOI url: https://doi.org/10.30574/msabp.2022.6.1.0068
Received on 24 April 2022; revised on 28 May 2022; accepted on 30 May 2022
 
Diabetes is a group of metabolic disorders characterized by poor insulin secretion or impaired insulin function both leading to hyperglycemia. One of the long-term complications of this disease process is neuropathy. Neuropathy, particularly in the extremities, leads to poor sensation, which contributes to the occurrence of ulcers typically observed on the feet of diabetic patients. Current treatments for diabetic ulcers include wound dressing, hyperbaric oxygen therapy, negative pressure therapy, and, in advanced cases, amputation of the limb.
 
Wound Healing; Diabetes; Chronic Wounds; Skin Substitutes; Skin Dressings; Matrices; ADM; Dermacell.
 
https://msabp.magnascientiapub.com/sites/default/files/fulltext_pdf/MSABP-2022-…

Preview Article PDF

Vangelis G Alexiou, Stylianos G. Koutsias and Bertasi Giampietro. The use of Dermacell® Allograft in a diabetic patient with critical limb ischemia. Magna Scientia Advanced Biology and Pharmacy, 2022, 6(1), 033-035. Article DOI: https://doi.org/10.30574/msabp.2022.6.1.0068

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 Magna Scientia Advanced Biology and Pharmacy - All rights reserved

Developed & Designed by VS Infosolution